Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response

J Antimicrob Chemother. 2021 Jan 1;76(1):277-279. doi: 10.1093/jac/dkaa415.

Minh Patrick Lê^{1

2}, Nathan Peiffer-Smadja^{3

4}, Jeremie Guedj⁴, Nadège Neant⁴, France Mentré⁴, Florence Ader^{5

6}, Yazdan Yazdanpanah^{3

4}, Gilles Peytavin^{1

4}; C-20-15 DisCoVeRy French Steering Committee

C-20-15 DisCoVeRy French Steering Committee:
Florence Ader, Yazdan Yazdanpanah, France Mentre, François-Xavier Lescure, Nathan Peiffer-Smadja, Lila Bouadma, Julien Poissy, Jean-François Timsit, Bruno Lina, Florence Morfin-Sherpa, Gilles Peytavin, Charles Burdet, Cedric Laouenan, Drifa Belhadi, Axelle Dupont, Basma Basli, Anissa Chair, Samira Laribi, Julie Level, Marion Schneider, Marie-Capucine Tellier, Aline Dechanet, Sandrine Couffin-Cadiergues, Christelle Delmas, Hélène Esperou, Claire Fougerou, Ambre Gelley, Laëtitia Moinot, Linda Wittkop, Carole Cagnot, Alpha Diallo, Soizic Le Mestre, Delphine Lebrasseur-Longuet, Noemie Mercier, Ventzislava Petrov-Sanchez, Vinca Icard, Benjamin Leveau, Johanna Guillon, Anne-Marie Taburet, Marion Noret, Eric d'Ortenzio, Oriane Puechal, Juliette Saillard, Caroline Semaille

¹ AP-HP, Bichat Claude Bernard Hospital, Pharmacology-Toxicology Department, 75018 Paris, France.
² INSERM, UMRS-1144, Université de Paris, 75006 Paris, France.
³ AP-HP, Bichat Claude Bernard Hospital, Tropical and infectious diseases Department, 75018 Paris, France.
⁴ IAME, INSERM, UMRS1137, Université de Paris, 75018 Paris, France.
⁵ Hospices Civils de Lyon, Department of Infectious Diseases, Croix-Rousse Hospital, 104 Grande-Rue de la Croix-Rousse, Lyon 69004, France.
⁶ Université Claude Bernard Lyon 1, Inserm, 1111, Centre International de Recherche en Infectiologie (CIRI) UCBL1, Lyon, France.

No abstract available

Publication types